The concept of embedding a spinel component in high capacity, composite xLi 2 MnO 3 •(1−x)LiMO 2 (M = Mn, Ni) 'layered-layered' structures to improve their electrochemical properties and cycling stability has been exploited. In this paper, we report the preparation and electrochemical characterization of three-component 'layered-layered-spinel' electrodes, synthesized by lowering the lithium content of a parent 'layered-layered' 0.3Li 2 MnO 3 •0.7LiMn 0.5 Ni 0.5 O 2 material while maintaining a Mn:Ni ratio of 0.65:0.35; such compounds can be designated generically by the system, Li x Mn 0.65 Ni 0.35 O y , for which the end members are 0.3Li 2 MnO 3 •0.7LiMn 0.5 Ni 0.5 O 2 (x = 1.3; y = 2.3), in which the average manganese and nickel oxidation states are 4+ and 2+, respectively, and LiMn 1.3 Ni 0.7 O 4 (x = 0.5; y = 2) in which the corresponding average oxidation states are expected to lie between 4+ and 3.77+ for Mn, and 2.57+ and 3+ for Ni, respectively. For this study, compounds with a lithium content of x = 1.3, i.e., the parent 'layered-layered' composition, and 1.25 were selected for detailed and comparative investigation, the latter value corresponding to a targeted spinel content of 6%. The beneficial effects of 1) using Mg 2+ as a dopant ion and 2) treating the electrode particle surface with an acidic solution of AlF 3 to enhance cycling stability, reduce first-cycle capacity loss, and to slow voltage decay on cycling are discussed.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: